Search

everythinglearnresearchcommunity

for

Search:↓

Better models and evaluation methods for alopecia areata are needed.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

The hepatitis B vaccine did not cause hair loss in the tested mice.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

Steroids are the best treatment for Alopecia Areata with few side effects.

Alopecia patients struggle with emotions and stress, and improving emotional intelligence may help manage hair loss.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Hair transplantation can effectively treat stable eyebrow hair loss in alopecia areata patients.

Using isotretinoin gel and minoxidil solution together effectively regrows hair in most people with patchy hair loss.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

SH-MSCs gel reduced IL-6 and increased TGF-β, suggesting it could treat alopecia.

Early recognition and treatment of atypical alopecia areata in infants are crucial.